XL-3 Xtra Cold and Cough (acetaminophen / chlorpheniramine / dextromethorphan / phenylephrine) Drug Interactions
A total of 968 drugs (5019 brand and generic names) are known to interact with XL-3 Xtra Cold and Cough (acetaminophen / chlorpheniramine / dextromethorphan / phenylephrine).
- 279 major drug interactions (1833 brand and generic names)
- 653 moderate drug interactions (2827 brand and generic names)
- 36 minor drug interactions (359 brand and generic names)
Check for interactions with XL-3 Xtra Cold and Cough (acetaminophen / chlorpheniramine / dextromethorphan / phenylephrine)
Common medications checked in combination with XL-3 Xtra Cold and Cough (acetaminophen / chlorpheniramine / dextromethorphan / phenylephrine)
- acetaminophen
- acetazolamide
- atorvastatin
- azithromycin
- Bactrim (sulfamethoxazole / trimethoprim)
- Bayer Aspirin (aspirin)
- benazepril
- carisoprodol
- clonazepam
- EpiPen 2-Pak (epinephrine)
- Lipitor (atorvastatin)
- loratadine
- metformin
- Metoprolol Tartrate (metoprolol)
- mirtazapine
- naproxen
- paroxetine
- tamsulosin
- Topamax (topiramate)
- tramadol
XL-3 Xtra Cold and Cough (acetaminophen / chlorpheniramine / dextromethorphan / phenylephrine) alcohol/food Interactions
There is 1 alcohol/food interaction with XL-3 Xtra Cold and Cough (acetaminophen / chlorpheniramine / dextromethorphan / phenylephrine)
XL-3 Xtra Cold and Cough (acetaminophen / chlorpheniramine / dextromethorphan / phenylephrine) disease Interactions
There are 12 disease interactions with XL-3 Xtra Cold and Cough (acetaminophen / chlorpheniramine / dextromethorphan / phenylephrine) which include:
- Alcoholism
- Liver Disease
- Anticholinergic Effects
- Cardiovascular Disease
- Pku
- Asthma/Copd
- Cardiovascular
- Renal/Liver Disease
- Psychiatric Conditions
- Bph
- Diabetes
- Glaucoma
See Also
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No information available. |
Do not stop taking any medications without consulting your healthcare provider.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
